Skip to main content
Clinical Trials/CTRI/2024/07/071093
CTRI/2024/07/071093
Completed
Not Applicable

A clinical study to evaluate the effectiveness of the test product on the tanned skin along with its safety on healthy adult female subjects.

Zydus Wellness Products Limited1 site in 1 country36 target enrollmentStarted: August 15, 2024Last updated:

Overview

Phase
Not Applicable
Status
Completed
Enrollment
36
Locations
1
Primary Endpoint
To assess the efficacy of test product on tanned skin, based on clinical, instrumental and subjective evaluations

Overview

Brief Summary

This is an open label, non-randomized, single-center, single-arm clinical study to evaluate the effectiveness of the test product on the tanned skin along with its safety on healthy adult female subjects.

The potential subjects will be screened as per the inclusion and exclusion criteria only after obtaining written informed consent from the subjects.

All eligible subjects will undergo clinical evaluation by a Dermatologist, instrument evaluation and subjective evaluation. Safety will be assessed throughout the study by monitoring adverse events.

Study Design

Study Type
Interventional
Allocation
Na
Masking
None

Eligibility Criteria

Ages
18.00 Year(s) to 45.00 Year(s) (—)
Sex
Female

Inclusion Criteria

  • Subjects with fitzpatrick skin type IV and V.
  • Subjects with visible skin tan on face, at least 2 shade darker than a Sun protected upper volar arm.
  • Subjects with at least 2 dark spots / blemishes.
  • Subjects willing to provide written informed consent to participate in the study.

Exclusion Criteria

  • Subjects with dark facial skin as determined by dermatologist.
  • Subjects who are receiving topical or systemic treatments for pigmentation within the last 30 days.
  • Subjects using other marketed skin lightening products during the study period or in the past 6 weeks.
  • Subjects using any other night cream during the study period.

Outcomes

Primary Outcomes

To assess the efficacy of test product on tanned skin, based on clinical, instrumental and subjective evaluations

Time Frame: Day 01, Day 03, Day 07, Day 14 and Day 28.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other [Health and Hygiene]
Responsible Party
Principal Investigator
Principal Investigator

Dr Bhagirath Patel

Cliantha Research

Study Sites (1)

Loading locations...

Similar Trials